Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for:

PFIZER-VACCINE/
RTXZXDO
May 23, 2013
Kathrin Jansen, senior vice president of Vaccine Research and Early Development at Pfizer Inc, poses...
PEARL RIVER, UNITED STATES
Jansen, senior vice president of Vaccine Research and Early Development at Pfizer Inc, poses in her lab...
Kathrin Jansen, senior vice president of Vaccine Research and Early Development at Pfizer Inc, poses for a portrait in one of her labs at Pfizer headquarters in Pearl River, New York, April 19, 2013. Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer. Jansen's next vaccine success could come by taming the superbug MRSA, a drug-resistant bacterium that she has seen ravage a healthy man up close and personally. Methicillin-resistant Staphylococcus aureus infects an estimated 53 million people globally and costs more than $20 billion a year to treat. Picture taken April 19, 2013. To match Feature PFIZER-VACCINE/ REUTERS/Carlo Allegri (UNITED STATES - Tags: BUSINESS HEALTH)
Sort by
Display
Items per page
Page
of 1